Top Markets
Coin of the day
Theseus Pharmaceuticals, Inc. Theseus Pharmaceuticals, Inc.

Theseus Pharmaceuticals, Inc.

THRX
Pozycja w akcjach #19949
Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on... Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and bringing to market targeted treatments for cancer patients. Their leading investigational compound, THE-630, is a pan-KIT inhibitor undergoing Phase I clinical trials for treating gastrointestinal stromal tumors. The company is also advancing a fourth-generation EGFR inhibitor specifically designed to combat the C797S EGFR mutation, which confers resistance to initial or later-line osimertinib therapy in individuals with non-small cell lung cancer. All their research and development efforts aim to overcome drug resistance mutations within key driver oncogenes, which are mutated genes that promote cancer. Founded in 2017, the company operates out of Cambridge, Massachusetts.
Cena akcji
$4.06
Ostatnia synchronizacja: 2024-02-23
Kapitalizacja rynkowa
$145.61M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Theseus Pharmaceuticals, Inc. (THRX)

Kategoria

Historia ceny akcji dla Theseus Pharmaceuticals, Inc. (THRX)
Najwyższa cena zamknięcia: $4.07 dnia 2024-02-01

Najniższa cena zamknięcia: $16.20 dnia 2021-10-01
Historia cen akcji firmy Theseus Pharmaceuticals, Inc. od 2021 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2024 5.46%
2023 -30.80%
2022 -54.19%
2021 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$553.09 42.20%
US
$1.02K 50.56%
NL
$158.64 525.80%
US
$122.47 -12.71%
AU
$772.27 8.67%
CH